LoginSignup
Hikma Pharma logo

Hikma Pharma

Stock
Stock
ISIN: GB00B0LCW083
Ticker: HIK
GB00B0LCW083
HIK

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Hikma Pharma has so far distributed $0.79 in 2024. The next dividend will be paid on 03.05.2025

$0.46

CHART BY

Frequently asked questions

What is Hikma Pharma's market capitalization?

The market capitalization of Hikma Pharma is 4.33B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Hikma Pharma's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Hikma Pharma is 19.16. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Hikma Pharma?

Hikma Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.019. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Hikma Pharma's stock?

Currently, 11 analysts cover Hikma Pharma's stock, with a consensus target price of 29.81. Analyst ratings provide insights into the stock's expected performance.

What is Hikma Pharma's revenue over the trailing twelve months?

Over the trailing twelve months, Hikma Pharma reported a revenue of 2.40B.

What is the EBITDA for Hikma Pharma?

Hikma Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 544.82M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Hikma Pharma?

Hikma Pharma has a free cash flow of 282.90M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Hikma Pharma have, and what sector and industry does it belong to?

Hikma Pharma employs approximately 9,100 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Generic industry.

What is the free float of Hikma Pharma's shares?

The free float of Hikma Pharma is 154.14M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
4.33B
EPS (TTM) 
$1.019
Free Float 
154.14M
P/E ratio (TTM) 
19.16
Revenue (TTM) 
2.40B
EBITDA (TTM) 
544.82M
Free Cashflow (TTM) 
282.90M

Pricing

1D span
$24.06$24.84
52W span
$21.81$27.36

Analyst Ratings

The price target is 29.81 and the stock is covered by 11 analysts.

Buy

7

Hold

4

Sell

0

Information

Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Generics segment focuses on oral and other non-injectable generic products, and is sold in the U.S. retail market. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd., and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.

Employees
9,100
Industries
Pharmaceuticals: Generic
Sector
Health Care

Identifier

ISIN
GB00B0LCW083
Primary Ticker
HIK

Knockouts

Join the conversation
Sign upLogin